Joint United Nations Programme on HIV/AIDS (UNAIDS). The Gap report. Geneva: UNAIDS, 2014.
Cunningham, ET Jr., Margolis, TP. Ocular manifestations of HIV infection. New England Journal of Medicine
1998; 339: 236–244.
Robinson, MR, Ross, ML, Whitcup, SM. Ocular manifestations of HIV infection. Current Opinion in Ophthalmology
1999; 10: 431–437.
Kestelyn, PG, Cunningham, ET. Jr.
HIV/AIDS and blindness. Bulletin of the World Health Organization
2001; 79: 208–213.
Freeman, WR, et al.
A prospective study of the ophthalmologic findings in the acquired immunodeficiency syndrome. American Journal of Ophthalmology
1984; 97: 133–142.
Salzberger, B, et al.
Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection
2005; 33: 345–349.
Accorinti, M, et al.
Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART. European Journal of Ophthalmology
2006; 16: 728–732.
Otiti-Sengeri, J, et al.
Ocular immune reconstitution inflammatory syndromes. Current Opinion in HIV and AIDS
2008; 3: 432–437.
Pathai, S, et al.
Increased ocular lens density in HIV-infected individuals with low nadir CD4 counts in South Africa: evidence of accelerated aging. Journal of Acquired Immune Deficiency Syndromes
2013; 63: 307–314.
Jabs, DA, et al.
Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome. American Journal of Ophthalmology
2015; 159: 1115–1122.
Guaraldi, G, et al.
Premature age-related comorbidities among HIV-infected persons compared with the general population. Clinical Infectious Diseases
2011; 53: 1120–1126.
Phillips, AN, Neaton, J, Lundgren, JD. The role of HIV in serious diseases other than AIDS. AIDS
2008; 22: 2409–2418.
Langelaan, M, et al.
Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiology
2007; 14: 119–126.
World Health Organisation. ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation, 2015.
The American Academy of Ophthalmology. Basic and Clinical Science Course, Section 1–13, 2015–2016. The American Academy of Ophthalmology (http://www.aao.org).
Lemp, MA, et al.
The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop (2007). Ocular Surface
2007; 5: 75–92.
Jeng, BH, et al.
Anterior segment and external ocular disorders associated with human immunodeficiency virus disease. Survey of Ophthalmology
2007; 52: 329–368.
Biswas, J, Sudharshan, S. Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. Indian Journal of Ophthalmology
2008; 56: 363–375.
Engstrom, RE Jr., et al.
Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. American Journal of Ophthalmology
1990; 109: 153–161.
Agarwal, A, et al.
Ocular manifestations in patients with human immunodeficiency virus infection in the Pre-HAART versus the HAART Era in the North Indian population. Ocular Immunology and Inflammation
Rasmussen, LD, et al.
Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study. Clinical Infectious Diseases
2011; 53: 1156–1163.
Lecuona, K, Cook, C. South Africa's cataract surgery rates: why are we not meeting our targets?
South African Medical Journal
2011; 101: 510–512.
Mertzanis, P, et al.
The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Investigative Ophthalmology and Visual Science
2005; 46: 46–50.